The Effect of Milk Components on the Response to Pneumococcal Vaccines in the Elderly Clinical Trial
Official title:
The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens: A Randomized Placebo-controlled Clinical Trial
Verified date | May 2017 |
Source | University of California, Davis |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to determine if the daily use of a certain amount and type of milk component for 2 months provides a significant stimulation to the immune system and specifically increases the chances of being protected against pneumonia after the vaccination.
Status | Completed |
Enrollment | 45 |
Est. completion date | June 2008 |
Est. primary completion date | June 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years and older |
Eligibility |
Inclusion Criteria: - Age and a willingness to participate Exclusion Criteria: - • Smoking history within 10 years - Underlying neoplasia or immunological disease - Use of oral cortisone or other immunosuppressive agents - Current consumption of milk and milk products greater than 1 unit of milk, 1 yogurt, or 1 serving of fresh cheese a day. - Food faddists or those taking a non-traditional diet - Current consumption of dietary supplements - People with a known history of milk allergy - People with chronic renal failure - People with chronic inflammatory diseases taking daily doses of NSAIDs for longer than 4 weeks at the time of enrollment. - Previous administration of the pneumomax vaccine - Reduced physical activity (i.e. NYHA classes III-IV) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of California, Davis |